Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134725) titled 'Esketamine as an adjuvant to erector spinae plane block for the prevention of chronic post-surgical pain after thoracoscopic lung resection: A multicenter randomized controlled trial' on Oct. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: 920th Hospital of the Joint Logistics Support Force
Condition:
Chronic postsurgical pain
Intervention:
Ropivacaine + Esketamine Group (Experimental Group):Ultrasound-guided erector spinae plane block will be performed at the T5 level, with injection of 20 mL of 0.25% ropivacaine combined with esketamine (0.2 mg/kg)
Recruitment Status: Not Rec...